Related Experiment Video

Updated: May 25, 2026

Isolation and Characterization of a Head and Neck Squamous Cell Carcinoma Subpopulation Having Stem Cell Characteristics
11:28

Isolation and Characterization of a Head and Neck Squamous Cell Carcinoma Subpopulation Having Stem Cell Characteristics

Published on: May 11, 2016

Alterations of Smad expression and activation in defining 2 subtypes of human head and neck squamous cell carcinoma

Wen Xie1, Seena Aisner, Soly Baredes

  • 1Department of Internal Medicine, UMDNJ-Robert Wood Johnson Medical School, Cancer Institute of New Jersey, New Brunswick, New Jersey, USA.

Head & Neck
|January 26, 2012
PubMed
Abstract

Insights

Disruptions in the transforming growth factor-beta (TGF-β)/Smad pathway are linked to head and neck squamous cell carcinoma (HNSCC). Loss of Smad2/3 activation in HNSCC tumors correlates with better patient survival, indicating distinct subtypes.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Signaling Pathways

Background:

  • The transforming growth factor-beta (TGF-β)/Smad signaling pathway plays a crucial role in cellular processes relevant to cancer development.
  • Dysregulation of this canonical pathway is hypothesized to contribute to the pathogenesis of head and neck squamous cell carcinoma (HNSCC).

Purpose of the Study:

  • To investigate the role of the TGF-β/Smad signaling pathway in HNSCC.
  • To determine the expression patterns of key pathway components (phospho-Smad2, phospho-Smad3, Smad4) in HNSCC tumors.
  • To assess the prognostic significance of Smad pathway alterations in HNSCC patients.

Main Methods:

  • Immunohistochemistry (IHC) was employed to analyze the expression of phospho-Smad2, phospho-Smad3, and Smad4.
  • A cohort of 798 HNSCC tumor samples from 346 patients was utilized for the analysis.

Main Results:

  • Loss of expression for pSmad2, pSmad3, or Smad4 was observed in 19%, 40%, and 12% of HNSCC specimens, respectively.
  • Smad2/3 activation was lost in 8.5% of specimens, and Smad4 expression was lost in 4% of specimens.
  • Patients with pSmad2/3-negative tumors exhibited significantly better overall survival compared to those with activated Smad2/3; Smad4 loss did not show prognostic significance.

Conclusions:

  • The findings suggest that HNSCC can be classified into distinct subtypes based on Smad pathway alterations.
  • Inactivation of Smad2/3 or loss of Smad4 expression defines specific HNSCC subtypes with differing clinical outcomes.
  • These distinct subtypes may require tailored therapeutic strategies for effective management of HNSCC.

More Related Videos

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment07:29

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

Published on: April 22, 2019

Genome-Wide Mapping of Histone Modifications and Transcription Factor Binding Sites in Neuroendocrine Small Cell Lung Cancer Cell Lines Using CUT&RUN11:50

Genome-Wide Mapping of Histone Modifications and Transcription Factor Binding Sites in Neuroendocrine Small Cell Lung Cancer Cell Lines Using CUT&RUN

Published on: April 3, 2026

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Cellular Adaptation IV: Dysplasia and Metaplasia01:24

Cellular Adaptation IV: Dysplasia and Metaplasia

DysplasiaDysplasia refers to abnormal changes in the size, shape, and organization of mature cells, characterized by pleomorphism, nuclear abnormalities, and increased mitotic activity. It commonly affects epithelial tissues, including the cervix, gastrointestinal tract, respiratory mucosa, and endometrium. Although it may occur alongside hyperplasia, dysplasia is not a true adaptive response but a preneoplastic change with potential to progress to cancer.When confined above the basement...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Chromatin Modification in iPS Cells01:32

Chromatin Modification in iPS Cells

Chromatin modification alters gene expression; therefore, scientists can add histone-modifying enzymes, histone variants, and chromatin remodeling complexes to somatic cells to aid reprogramming into pluripotent stem (iPS) cells.
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...